Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up
Titel:
Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up
Auteur:
Rodrigo, Sander F. Ramshorst, Jan van Hoogslag, Georgette E. Boden, Helèn Velders, Matthijs A. Cannegieter, Suzanne C. Roelofs, Helene Younis, Imad Al Dibbets-Schneider, Petra Fibbe, Willem E. Zwaginga, Jaap Jan Bax, Jeroen J. Schalij, Martin J. Beeres, Saskia L. Atsma, Douwe E.